Implications of the European organisation for research and treatment of cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care

  1. Pettengell, R.
  2. Aapro, M.
  3. Brusamolino, E.
  4. Caballero, D.
  5. Coiffier, B.
  6. Pfreundschuh, M.
  7. Trneny, M.
  8. Walewski, J.
Revue:
Clinical Drug Investigation

ISSN: 1173-2563 1179-1918

Année de publication: 2009

Volumen: 29

Número: 8

Pages: 491-513

Type: Révision

DOI: 10.2165/00044011-200929080-00001 GOOGLE SCHOLAR